| Abstract | Australasian marsupials, especially wallabies, are highly susceptible to clinical toxoplasmosis. This paper describes the use of atovaquone for effective treatment of toxoplasmosis in 4 Bennett's wallabies (Macropus rufogriseus), along with the serology, isolation of Toxoplasma gondii, and genotyping of 3 T. gondii isolates from 5 captive wallabies. This is the first report of success in treating acute toxoplasmosis in wallabies, the first report of serology followed over a significant period of time, and the first report of isolation and genetic typing of T. gondii from wallabies in the United States. |
| Authors | J P Dubey, C Crutchley
(Affiliation: United States Department of Agriculture, Agricultural Research Service, Animal and Natural Resources Institute, Animal Parasitic Diseases Laboratory, Beltsville, Maryland 20705-2350, USA. jitender.dubey at ars.usda.gov)
|
| Journal | The Journal of parasitology
(J Parasitol)
Vol. 94
Issue 4
Pg. 929-33
(Aug 2008)
ISSN: 0022-3395 United States |
| PMID | 18576797
(Publication Type: Journal Article)
|
| Chemical References |
- Anti-Infective Agents
- Atovaquone
|
| Topics |
- Animals
- Anti-Infective Agents
(therapeutic use)
- Atovaquone
(therapeutic use)
- Biological Assay
(veterinary)
- Cats
- Female
- Macropodidae
(parasitology)
- Male
- Mice
- Toxoplasma
(isolation & purification)
- Toxoplasmosis, Animal
(drug therapy, parasitology)
- Toxoplasmosis, Ocular
(drug therapy, parasitology, veterinary)
|
